Tower Research Capital LLC (Trc) Enanta Pharmaceuticals Inc Transaction History

Tower Research Capital LLC (Trc)

$3.53 Billion
Q2 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,021 shares of ENTA stock, worth $34,444. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,021

Previous 2,235 124.65%

Holding current value

$34,444

Previous $12,000 208.33%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$4.26 - $7.95 $11,868 - $22,148	2,786 Added 124.65%	5,021 $37,000
Q1 2025 May 15, 2025	SELL	$4.82 - $8.49 $23,940 - $42,169	-4,967 Reduced 68.97%	2,235 $12,000
Q4 2024 Feb 13, 2025	BUY	$5.75 - $12.99 $13,075 - $29,539	2,274 Added 46.14%	7,202 $41,000
Q3 2024 Nov 14, 2024	BUY	$10.05 - $16.54 $21,135 - $34,783	2,103 Added 74.44%	4,928 $51,000
Q2 2024 Aug 13, 2024	BUY	$11.43 - $17.02 $14,950 - $22,262	1,308 Added 86.22%	2,825 $36,000
Q1 2024 May 15, 2024	SELL	$10.08 - $17.46 $50,238 - $87,020	-4,984 Reduced 76.67%	1,517 $26,000
Q4 2023 Feb 13, 2024	BUY	$8.18 - $10.78 $2,265 - $2,986	277 Added 4.45%	6,501 $61,000
Q3 2023 Nov 14, 2023	BUY	$11.09 - $22.13 $46,555 - $92,901	4,198 Added 207.21%	6,224 $69,000
Q2 2023 Aug 14, 2023	BUY	$20.68 - $39.85 $18,632 - $35,904	901 Added 80.09%	2,026 $43,000
Q1 2023 May 09, 2023	BUY	$38.82 - $54.59 $30,667 - $43,126	790 Added 235.82%	1,125 $46,000
Q4 2022 Feb 10, 2023	SELL	$40.77 - $53.73 $236,873 - $312,171	-5,810 Reduced 94.55%	335 $15,000
Q3 2022 Nov 10, 2022	SELL	$48.29 - $71.27 $293,168 - $432,680	-6,071 Reduced 49.7%	6,145 $319,000
Q2 2022 Aug 15, 2022	BUY	$38.13 - $76.93 $60,550 - $122,164	1,588 Added 14.94%	12,216 $577,000
Q1 2022 May 12, 2022	BUY	$56.06 - $74.11 $425,102 - $561,976	7,583 Added 249.03%	10,628 $757,000
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $100,095 - $161,926	1,663 Added 120.33%	3,045 $228,000
Q3 2021 Nov 15, 2021	SELL	$41.02 - $58.65 $369 - $527	-9 Reduced 0.65%	1,382 $79,000
Q2 2021 Aug 16, 2021	SELL	$43.76 - $53.11 $13,171 - $15,986	-301 Reduced 17.79%	1,391 $61,000
Q1 2021 May 17, 2021	BUY	$41.69 - $54.95 $32,184 - $42,421	772 Added 83.91%	1,692 $84,000
Q4 2020 Feb 16, 2021	SELL	$41.16 - $47.47 $16,916 - $19,510	-411 Reduced 30.88%	920 $39,000
Q3 2020 Nov 16, 2020	SELL	$43.36 - $53.53 $73,104 - $90,251	-1,686 Reduced 55.88%	1,331 $61,000
Q2 2020 Aug 13, 2020	BUY	$46.37 - $57.58 $139,898 - $173,718	3,017 New	3,017 $151,000
Q4 2019 Feb 07, 2020	SELL	$57.95 - $66.61 $17,211 - $19,783	-297 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$60.08 - $88.17 $17,843 - $26,186	297 New	297 $18,000
Q2 2019 Aug 13, 2019	SELL	$81.3 - $97.35 $13,089 - $15,673	-161 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$69.08 - $105.66 $11,121 - $17,011	161 New	161 $15,000
Q4 2018 Feb 14, 2019	SELL	$65.41 - $84.65 $65 - $84	-1 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$85.46 - $126.37 $85 - $126	1 New	1 $0

Others Institutions Holding ENTA

# of Institutions

106

Shares Held

18.7M

Call Options Held

50K

Put Options Held

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $142M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Enanta Pharmaceuticals Inc Transaction History